ALGEN genOway Société anonyme

EPA · FR · Healthcare · Biotechnology · genoway.com

2.280EUR+3.64%Mkt Cap: 30.58M $P/E: —Today

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as k…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

Genmab A/S - American Depositary Shares

$21.69BUSDP/E 27.4

JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap30.58M USD

Enterprise Value—

Revenue (TTM)28.29M USD

Gross Profit11.14M USD

Net Income (TTM)1.01M USD

Revenue/Share—

Last Price2.280 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees—

CountryFR

SectorHealthcare

IndustryBiotechnology

ISINFR0004053510

Valuation

P/E (Trailing)—

P/E (Forward)14.67

PEG—

EV/EBITDA—

EV/Revenue—

P/S1.04

P/B1.20

EPS (TTM)-0.15

EPS (Forward)0.15

52W Range

2.01025% of range3.070

52W High3.070 EUR

52W Low2.010 EUR

Profitability

Gross Margin48.90%

Oper. Margin9.28%

EBITDA Margin17.01%

Profit Margin4.43%

ROE3.71%

ROA2.05%

Growth

Revenue Growth6.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.55M USD

CapEx (TTM)11.88M USD

FCF Margin-44.69%

FCF Yield-41.35%

Net Debt7.30M USD

Net Debt/EBITDA1.52

Balance Sheet

Debt/Equity0.55

Current Ratio3.14

Quick Ratio2.96

Book Value/Sh1.83 EUR

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.12.34M

Float—

Insiders31.39%

Institutions13.81%

Technical

SMA 502.446 (-6.8%)

SMA 2002.450 (-6.9%)

Beta0.37

S&P 52W Chg14.58%

Avg Vol (30d)6.10K

Avg Vol (10d)11.26K

Technical Indicators

RSI (14)26.1

MACD-0.0489

MACD Signal-0.0267

MACD Hist.-0.0223

BB Upper2.569 EUR

BB Middle2.405 EUR

BB Lower2.241 EUR

BB Width13.62%

ATR (14)0.0665 EUR

Vol Ratio (20d)2.27x